The U.S. Food and Drug Administration (FDA) has announced another round of enhancements to its Center for Tobacco Products (CTP) Portal NextGen, introducing new tools designed to simplify the submission process for tobacco product applications. Alongside these updates, the agency confirmed it will phase out the use of eSubmitter for Premarket Tobacco Product Applications (PMTAs) and Substantial Equivalence (SE) reports later this year. 

For manufacturers preparing regulatory submissions, these changes represent an important shift in how PMTAs and SE reports will be submitted moving forward. 

What Is CTP Portal NextGen? 

Originally launched in 2025, CTP Portal NextGen is FDA's web-based platform for electronically submitting tobacco product applications and regulatory documents. 

Unlike the previous workflow, which relied heavily on the standalone eSubmitter software, NextGen allows applicants to complete forms, upload documents, validate submissions, and communicate directly through a single online portal. 

According to FDA, the latest updates are intended to improve efficiency while reducing the administrative burden associated with complex tobacco product submissions. 

New Features Designed to Simplify Submissions 

FDA has introduced several new capabilities based on feedback from industry users. 

Folder Upload Support 

Applicants can now upload entire folders and subfolders rather than selecting files individually. 

For companies submitting large PMTA or SE applications with extensive supporting documentation, this feature should significantly reduce upload time and simplify document organization. 

Document Labeling Within the Portal 

Users can now identify and label documents directly inside CTP Portal NextGen before submission. 

This helps ensure supporting materials are properly categorized and reduces the likelihood of missing or incorrectly organized files. 

Reusable Contact Information 

The portal now includes an address book feature that allows users to save contact information for future submissions. 

For companies that regularly submit applications or amendments, this eliminates repetitive data entry and streamlines future filings. 

eSubmitter Will Be Phased Out for PMTAs and SE Reports 

One of the most significant announcements is FDA's decision to discontinue the use of eSubmitter for two major submission types: 

• Premarket Tobacco Product Applications (PMTAs)  

• Substantial Equivalence (SE) Reports  

Important Deadline 

Beginning November 14, 2026, applicants should use the web-based forms available through CTP Portal NextGen when submitting PMTAs and SE reports. 

After that date: 

• eSubmitter will no longer support PMTA submissions.  

• eSubmitter will no longer support SE submissions.  

Manufacturers planning future applications should begin transitioning to the web portal well before the deadline to avoid delays. 

What About Other Submission Types? 

The transition is currently limited to PMTAs and SE reports. 

For other tobacco product submissions—including: 

• Ingredient listings  

• Harmful and Potentially Harmful Constituents (HPHC) reports  

• Exemption requests  

• Other regulatory submissions  

the existing eSubmitter process will remain in place for now. 

FDA has indicated that additional web-based forms will be introduced in future phases as CTP Portal NextGen continues to expand. 

PDF Forms Are Still Available 

FDA recognizes that not every applicant may be able to submit directly through the online portal. 

For those situations, PDF versions of the required forms will continue to be available. 

Applicants using PDF forms should remember: 

• Always download the latest version directly from FDA before preparing a submission.  

• Incomplete or outdated forms may result in the agency refusing to accept the application.  

• When submitting through CTP Portal NextGen's web forms, separate PDF forms are not required.  

What This Means for Manufacturers 

Companies preparing PMTAs or SE reports should begin familiarizing themselves with CTP Portal NextGen now rather than waiting until the November deadline. 

Transitioning early offers several advantages: 

• Reduced administrative workload  

• Faster document organization  

• Improved submission consistency  

• Less manual data entry  

• Better preparation before eSubmitter is retired  

Organizations that regularly submit FDA applications may also benefit from updating internal standard operating procedures (SOPs) and training regulatory staff on the new portal features. 

Preparing for the Transition 

As FDA continues modernizing its electronic submission process, manufacturers should review their current workflows and determine whether updates are needed before eSubmitter is retired for PMTA and SE filings. 

Early adoption of CTP Portal NextGen can help reduce disruptions and ensure future submissions align with FDA's evolving expectations. 

MiPod Wholesale Will Continue Monitoring FDA Regulatory Updates 

Regulatory requirements continue to evolve as FDA modernizes its submission systems and expands digital tools for tobacco product applications. 

MiPod Wholesale will continue tracking FDA guidance, PMTA developments, and regulatory changes to help manufacturers, distributors, and industry partners stay informed and prepared for upcoming compliance deadlines.